DeltaScan Validation Study for the Assessment of Delirium in the ICU and on Wards (Val3)
A Prospective Multicenter Clinical Validation Study of DeltaScan for the Assessment of Delirium in the Intensive Care Unit and on Wards
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
A observational or N/A phase clinical study on Delirium, this trial is completed. The trial is conducted by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Mar 2022 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jun 2019 — Jan 2021 [monthly]
Recruiting
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Amphia Hospital
- Diakonessenhuis, Utrecht
- Erasmus Medical Center
- European Union
- Franciscus Gasthuis
- Isala
- OLVG
- Prolira
- Radboud University Medical Center
- St. Antonius Hospital
- Tergooi Hospital
- UMC Utrecht
For direct contact, visit the study record on ClinicalTrials.gov .